Early testing in cultured human lung and airway cells suggests that a broad-spectrum, oral antiviral drug called #EIDD2801 could aid the fight against SARS-CoV-2, the virus behind the #COVID19 pandemic. Check out the new results in @ScienceTM: https://t.co/mgSup1euj0 pic.twitter.com/4pG0XKNIFh

— Science Magazine (@ScienceMagazine) April 9, 2020